Atlas Trials

Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy

Clinical trial NCT05204394 · UNKNOWN

Trial details

NCT number
NCT05204394
Sponsor
Viriom
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
HIV-1-infection
Start date
2022-04-01
Primary completion
2023-09-30
Enrollment
438

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.